Chemed Corp (NYSE:CHE)

$ 565.98 3.93 (0.7%) Market Cap: 8.48 Bil Enterprise Value: 8.31 Bil PE Ratio: 28.60 PB Ratio: 6.86 GF Score: 94/100

Q3 2024 Chemed Corp Earnings Call Transcript
Oct 30, 2024

$535.8 (-12.14%)

Earnings
Q2 2024 Chemed Corp Earnings Call Transcript
Jul 25, 2024

$540.97 (-1.19%)

Earnings
Q1 2024 Chemed Corp Earnings Call Transcript
Apr 25, 2024

$573.34 (-7.22%)

Earnings
Q4 2023 Chemed Corp Earnings Call Transcript
Feb 28, 2024

$628.84 (+5.40%)

Earnings
Chemed Corp at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Chemed Corp at Bank of America Home Care Conference (Virtual) Transcript
Dec 04, 2023
Q3 2023 Chemed Corp Earnings Call Transcript
Oct 26, 2023

$554.24 (+9.32%)

Earnings
Q2 2023 Chemed Corp Earnings Call Transcript
Jul 27, 2023

$520.74 (-8.10%)

Earnings
Chemed Corp at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Chemed Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023
Chemed Corp at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Chemed Corp Earnings Call Transcript
Apr 27, 2023

$544.42 (-2.90%)

Earnings
Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 14, 2023
Q4 2022 Chemed Corp Earnings Call Transcript
Feb 24, 2023

$529.97 (+3.66%)

Earnings
Chemed Corp at Bank of America Securities Home Care Conference (Virtual) Transcript
Dec 05, 2022
Chemed Corp at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022
Q3 2022 Chemed Corp Earnings Call Transcript
Nov 01, 2022

$476.93 (+2.15%)

Earnings
Q2 2022 Chemed Corp Earnings Call Transcript
Jul 28, 2022

$482.67 (-7.90%)

Earnings
Chemed Corp at Jefferies Healthcare Conference Transcript
Jun 09, 2022
Chemed Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 18, 2022
Chemed Corp at Bank of America Healthcare Conference Transcript
May 10, 2022
Q1 2022 Chemed Corp Earnings Call Transcript
Apr 27, 2022

$489.6 (+1.73%)

Earnings
Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 16, 2022
Q4 2021 Chemed Corp Earnings Call Transcript
Feb 25, 2022

$480.78 (+4.75%)

Earnings
Chemed Corp at Bank of America Securities Home Care Conference (Virtual) Transcript
Dec 07, 2021
Q3 2021 Chemed Corp Earnings Call Transcript
Oct 29, 2021

$482.25 (+7.89%)

Earnings
Q2 2021 Chemed Corp Earnings Call Transcript
Jul 28, 2021

$457.01 (-4.83%)

Earnings
Chemed Corp at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021
Chemed Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Chemed Corp Earnings Call Transcript
Apr 28, 2021

$472.85 (+2.96%)

Earnings
Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 17, 2021
Q4 2020 Chemed Corp Earnings Call Transcript
Feb 24, 2021

$473.27 (-1.62%)

Earnings
Chemed Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2020
Q3 2020 Chemed Corp Earnings Call Transcript
Oct 30, 2020

$478.32 (+1.01%)

Earnings
Q2 2020 Chemed Corp Earnings Call Transcript
Jul 30, 2020

$496.61 (+5.65%)

Earnings
Chemed Corp at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2020
Chemed Corp Annual Shareholders Meeting Transcript
May 18, 2020
Chemed Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 12, 2020
Q1 2020 Chemed Corp Earnings Call Transcript
Apr 29, 2020

$438.91 (+0.40%)

Earnings
Q4 2019 Chemed Corp Earnings Call Transcript
Feb 19, 2020

$507.2 (+3.18%)

Earnings
Chemed Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 13, 2019
Q3 2019 Chemed Corp Earnings Call Transcript
Oct 30, 2019

$402 (-2.47%)

Earnings
Q2 2019 Chemed Corp Earnings Call Transcript
Jul 26, 2019

$386.01 (+3.28%)

Earnings
Chemed Corp at Jefferies Healthcare Conference Transcript
Jun 05, 2019
Chemed Corp at RBC Capital Markets Healthcare Conference Transcript
May 21, 2019
Chemed Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
Q1 2019 Chemed Corp Earnings Call Transcript
Apr 30, 2019

$326.78 (-1.16%)

Earnings
Chemed Corp at Oppenheimer Healthcare Conference Transcript
Mar 19, 2019
Q4 2018 Chemed Corp Earnings Call Transcript
Feb 21, 2019

$318.99 (+0.79%)

Earnings

Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 16, 2022 / 12:40PM GMT

Release Date Price: $483.01 (+1.20%)

Transcript

Michael David Wiederhorn

Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Good morning, and welcome to Day 2 of Oppenheimer's 32nd Annual Healthcare Conference. My name is Michael Wiederhorn. I'm the health care services analyst here. Today, we're hosting Chemed. We have President and CEO, Kevin McNamara; Chief Financial Officer, David Williams; President and CEO of VITAS, Nick Westfall. So today is going to be a fireside chat format for the audience. We should -- there should be a Q&A portal on the top right corner of your screen to submit questions, and feel free to use that function.

Questions & Answers

Michael David Wiederhorn

Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

So good morning, guys. Thanks for coming. Thanks. And hopefully, this will be our last virtual hopefully, next year, we'll be back in person. Welcome. So I'll just kind of jump right into it here with kind of a broad question. Just kind of can you update us what you're seeing in terms of emissions and expenses trends post on

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.